bioAffinity Technologies Inc. (BIAF) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

bioAffinity Technologies ...

NASDAQ: BIAF · Real-Time Price · USD
0.29
0.01 (2.04%)
At close: Jun 09, 2025, 3:59 PM

bioAffinity Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.11M 2.82M 11.41M 1.36M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
19.68K 16.06K 6K 10.44K
Receivables
1.14M 811.67K 10.49K 1.53K
Inventory
27.61K 18.48K 5.54K 71.85K
Other Current Assets
147.18K 124.69K 191.82K 59.3K
Total Current Assets
2.7M 3.97M 11.96M 1.44M
Property-Plant & Equipment
1.62M 1.99M 214.44K 4.63K
Goodwill & Intangibles
2.18M 2.24M n/a n/a
Total Long-Term Assets
3.82M 4.25M 220.44K 15.07K
Total Assets
6.51M 8.22M 12.18M 1.45M
Account Payables
987.31K 604.79K 345.04K 230.41K
Deferred Revenue
24.4K 33.06K n/a n/a
Short-Term Debt
694.47K n/a 251.75K 11.2M
Other Current Liabilities
1.08M 857.04K n/a n/a
Total Current Liabilities
3.1M 2.25M 1.14M 13.04M
Long-Term Debt
20.18K n/a n/a 160.18K
Other Long-Term Liabilities
n/a n/a n/a 4.04M
Total Long-Term Liabilities
806.73K 1.12M 596.79K 4.2M
Total Liabilities
3.91M 3.37M 1.14M 17.24M
Total Debt
1.5M 1.58M 251.75K 11.36M
Common Stock
106.59K 65.76K 58.67K 18.74K
Retained Earnings
-53.64M -44.6M -36.67M -28.51M
Comprehensive Income
n/a n/a n/a -4.04M
Shareholders Equity
2.6M 4.86M 11.04M -15.79M
Total Investments
n/a n/a n/a n/a